Allworth Financial’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Allworth Financial’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1	Closed	–	–	2980
2022 Q1	$0	Hold	1	–	–	﹤0.01%	2479
2021 Q4	$0	Hold	1	–	–	﹤0.01%	2200
2021 Q3	$0	Hold	1	–	–	﹤0.01%	2018
2021 Q2	$0	Hold	1	–	–	﹤0.01%	1712
2021 Q1	$0	Hold	1	–	–	﹤0.01%	1659
2020 Q4	$0	Hold	1	–	–	﹤0.01%	1466
2020 Q3	$0	Hold	1	–	–	﹤0.01%	1299
2020 Q2	$0	Buy	+1	New	+$67	﹤0.01%	1419

Other funds holding EVFM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Allworth Financial's EVFM Position: Q2 2022 in Review

Allworth Financial sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q2 2022, closing a stake of 1 share.

Allworth Financial first reported a position in EVFM in Q2 2020 and held it in 8 quarters. The position peaked at $0 in Q1 2022. 44 funds tracked by Wall St. Rank hold EVFM as of Q2 2022.

Allworth Financial reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Allworth Financial sold 1 Evofem Biosciences, Inc. Common Stock share in Q2 2022.
Allworth Financial first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2020 and held it in 8 quarters.
Allworth Financial's Evofem Biosciences, Inc. Common Stock position peaked at $0 in Q1 2022.
44 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q2 2022.

Based on Allworth Financial's 13F filing for Q2 2022, filed 13 Jul 2022.